Neurosurgery & Trauma
From the Journals
Motor function restored in three men after complete paralysis from spinal cord injury
A system developed specifically for spinal cord injuries enabled three men with complete paralysis to stand, walk, cycle, swim, and move their...
Latest News
Cement found in man’s heart after spinal surgery
The cement had leaked into the patient’s body, hardened, and traveled to his heart.
From the Journals
Near-hanging injuries: Critical care, psychiatric management
Near hanging refers to strangulation or hanging that doesn’t immediately lead to death.
News from the FDA/CDC
TBI deaths from falls on the rise
Death rates from such traumatic brain injuries were up significantly in 29 states from 2008 to 2017, but no state had a significant decrease.
Conference Coverage
Staged hemispheric embolization: How to treat hemimegalencephaly within days of birth
“Neurosurgeons won’t touch them.”
From the Journals
Hyperphosphorylated tau visible in TBI survivors decades after brain injury
The study suggests that tau brain imaging can provide valuable information about TBI and might be able to identify patients who could benefit from...
Conference Coverage
Epilepsy surgery outcome prediction seeks to gain ground
BANGKOK – It’s time for the prediction of seizure outcomes after epilepsy surgery to step into the 21st century.
From the Journals
Researchers examine potential causes of dementia in CTE
More years of football play were associated with white matter changes and tau accumulation, which were associated with increased risk of dementia...
Literature Review
Nerve transfer improves function after spinal cord injury
The procedure is safe, and combining it with tendon transfer could maximize functional benefit for patients with upper limb paralysis.
From the Journals
‘Trigger zone’ resection ups seizure-free odds in temporal lobe epilepsy
The findings, if confirmed in prospective interventional trials, could have important implications for surgery and drug development.
News
Minimally invasive ICH lysis safely helps when clot adequately shrinks
HONOLULU – The primary endpoint from the phase 3 MISTIE III trial was neutral, apparently because clot lysis often fell short.